×
Recreational 2-Methyl-2-Butanol Use: An Emerging Wave of Misuse of an Ethanol Substitute on the Horizon? PDF
$ 40.00
Recreational 2-Methyl-2-Butanol Use: An Emerging Wave of Misuse of an Ethanol Substitute on the Horizon? PDF quantity
$ 40.00
×
Quetiapine-Induced Acute-Onset Catatonia PDF
$ 40.00
Quetiapine-Induced Acute-Onset Catatonia PDF quantity
$ 40.00
×
An Open-Label Study of Amisulpride in the Treatment of Mania PDF
$ 40.00
An Open-Label Study of Amisulpride in the Treatment of Mania PDF quantity
$ 40.00
×
Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF
$ 40.00
Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF quantity
$ 40.00
×
Identification of a Claims Data "Signature" and Economic Consequences for Treatment-Resistant Depression PDF
$ 40.00
Identification of a Claims Data "Signature" and Economic Consequences for Treatment-Resistant Depression PDF quantity
$ 40.00
×
Got 2 Good Eyes But You Still Can’t See: An Atypical Case of Wernicke’s Encephalopathy PDF
$ 40.00
Got 2 Good Eyes But You Still Can’t See: An Atypical Case of Wernicke’s Encephalopathy PDF quantity
$ 40.00
×
Acute Blood Pressure Changes Associated With Antipsychotic Administration to Psychiatric Inpatients PDF
$ 40.00
Acute Blood Pressure Changes Associated With Antipsychotic Administration to Psychiatric Inpatients PDF quantity
$ 40.00
×
Sleep and Depression PDF
$ 40.00
Sleep and Depression PDF quantity
$ 40.00
×
Migraine Prevalence, Characteristics, Triggers, and Coping Strategies Among Medical Students in Saudi Arabia PDF
$ 40.00
Migraine Prevalence, Characteristics, Triggers, and Coping Strategies Among Medical Students in Saudi Arabia PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder PDF
$ 40.00
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
The Efficacy of Acute Electroconvulsive Therapy in Atypical Depression PDF
$ 40.00
The Efficacy of Acute Electroconvulsive Therapy in Atypical Depression PDF quantity
$ 40.00
×
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease PDF
$ 40.00
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart